TetraPhase PharmaceuticalsAnnounces Closing Of Public Offering Of Common Stock

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced the closing of its underwritten public offering of 4,542,500 shares of common stock at an offering price of $19.00 per share. The shares of common stock issued and sold in the offering at the closing include 592,500 shares issued upon the exercise in full by the underwriters of their option at the offering price. The gross proceeds to Tetraphase from this offering were $86.3 million, before deducting underwriting discounts and commissions and offering expenses payable by Tetraphase.

Help employers find you! Check out all the jobs and post your resume.

Back to news